A collage photo of Hagop Youssoufian and AffyImmune Therapeutics.
Apr 14, 2024, 06:47
Hagop Youssoufian: I’m very pleased to serve on the Clinical and Regulatory Advisory Board of AffyImmune Therapeutics
Hagop Youssoufian, Youssoufian Consulting, LLC, posted on LinkedIn:
“I’m very pleased to serve on the Clinical and Regulatory Advisory Board of AffyImmune Therapeutics, which is aspiring to develop revolutionary CAR T therapies for a highly lethal form of thyroid cancer as well as lung cancer.”
View the article attached to the post.
Source: Hagop Youssoufian/LinkedIn
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 1, 2025, 19:09
Apr 1, 2025, 18:48
Apr 1, 2025, 18:37
Apr 1, 2025, 18:26
Apr 1, 2025, 18:22